Results
Filtros
“The cycle is now national”: Anvisa's CEO details new milestone in cannabis cultivation and predicts up to 60% cost reduction
In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil
Arrival of gummies sparks debate on expanding medical cannabis in the U.S.
Measure comes as the state government pressures the Legislature to include new diseases in the program
Why does cannabis treatment need to be personalized?
Deusa Cast episode addresses safety, oversight, and the role of compounding pharmacy in building personalized treatments, including medical cannabis
Validity of Cannabis: Importance of Storage on Therapeutic Properties
The preservation of cannabinoids and the effectiveness of treatment depend directly on strict control of light and humidity
Hemp Roots Enter Science Radar in Study on Childhood Cancer
USDA study identified compounds in hemp roots with activity against pediatric cancer cells, pointing to new possibilities for scientific research
Uruguay cannabis sales hit record and grow by one ton in 2025
Driven by the Epsilon variant, cannabis sales at pharmacies reach a historic mark with high consumer preference for higher THC content
France extends medicinal cannabis program, but definitive regulation remains undefined
Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU
CBG-rich Cannabis undergoes unprecedented evaluation at CTNBio
Process could determine whether the genetics will be classified as a genetically modified organism or treated as a conventional plant in Brazil
STF debates legal nature and rules for the supply of cannabidiol
Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol by the SUS
Study points to new method for accurately identifying Cannabis cultivars
Research published in the Journal of Cannabis Research combines genetic and chemical analysis to enhance quality control in the pharmaceutical industry
The Year of Cannabis: trends and projections for the market in 2026
Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year
South Africa starts pilot planting with local hemp seeds
Initiative in the Limpopo province tests national hemp genetics to boost rural and economic development
Bill on medicinal cannabis advances in German Parliament amid technical criticisms
Bill on medicinal cannabis in Germany enters a decisive phase in Parliament and receives warnings from experts about regulatory and implementation challenges
After Tooth Extractions, Cannabidiol Emerges as an Option for Pain
According to dentist Cynthia De Carlo, studies indicate that cannabidiol may provide effective analgesia after tooth extractions, especially for patients with restrictions on traditional painkillers.
UFLA integrates group presenting document to Anvisa on cannabis in scientific research and therapeutic use
Letter brings together experts from across the country and includes UFLA participation
Sergipe discusses expanding medical cannabis policy in SUS
Meeting of the State Health Council discussed new protocols and free access to cannabis-based products in the public network
CBD Market in Spain grows 35% per year, but stalls in regulation
Sector already generates €136 million, has over 500 stores, and operates below its potential due to outdated laws
CBD Market in Spain grows 35% annually, but stalls in regulation
Sector already generates €136 million, with over 500 stores and operating below potential due to outdated laws
Canopy Growth announces acquisition of MTL Cannabis in $179 million transaction
Deal aims to consolidate Canopy Growth's leadership in the Canadian medicinal market and expand operations in Quebec; MTL founders to remain in management
Cannabis cultivation and regulatory standards review stand out in the 2026–2027 Regulatory Agenda
Approved document defines 161 priority topics for the next two years, including national cultivation of low-THC cannabis